Delhi High Court Holds That Trademark Proprietor Cannot Claim Monopoly Over Entire Class of Goods

Summary

The Delhi High Court clarified that trademark protection extends only to the specific goods within the class for which the mark is registered, and a proprietor cannot claim exclusivity over all goods in that class merely because of a similar mark, particularly when not using the mark for those goods.

Introduction

This appeal challenges the judgment of the Patiala House District Court, which dismissed the Appellant's application for interim injunction under Order 39 Rules 1 and 2 of the Code of Civil Procedure, 1908. The underlying suit seeks permanent injunction restraining the Respondent from using the trademark "PRUEASE" (Impugned Mark) on the ground that it is deceptively similar to the Appellant's trademark "PRO-EASE" (Subject Mark). Both marks are registered in Class 5 of the Trade Marks Registry, but are used for entirely different product categories within that class.

Background and Facts

The Appellant conceived and adopted the Subject Mark "PRO-EASE" in 2012 for use in relation to sanitary napkins, sanitary towels, sanitary pads, menstruation pads, menstruation briefs, sanitary panties, panty liners for hygienic or menstrual purposes, deodorizing agents and refresheners, panty shields for hygienic or menstrual purposes, menstruation tampons, sanitary wipes, paper wipes impregnated with sanitizers, paper wipes impregnated with disinfectants, and allied and other cognate goods. The Respondents, on the other hand, adopted the Impugned Mark "PRUEASE" in 2017 for medicinal and pharmaceutical preparations specifically intended for treating constipation, containing the active pharmaceutical ingredient Prucalopride.

Appellant's Contentions

The Appellant contended that the learned District Judge failed to appreciate that the Appellant is entitled to extend the use of the Subject Mark to allied and cognate goods, including pharmaceuticals for treating menstrual cramps and other related conditions. The Appellant argued that the Respondents cannot be permitted to adopt a deceptively similar mark merely on the basis that the Appellant is not presently using its trademark for those particular pharmaceutical goods. The Appellant further submitted that as the registered proprietor of the Subject Mark in Class 5, it is entitled to protection against the Respondents' unauthorized use, and that the Respondents cannot claim proprietorship over a similar mark within the same class.

Respondent's Contentions

The Respondents submitted that they independently conceived and adopted the Impugned Mark for medicinal and pharmaceutical preparations and have been continuously using it since 2017 without interruption. They contended that the element "PRU" in their mark is derived from the active pharmaceutical ingredient Prucalopride, while "Ease" denotes ease or relief from constipation. According to the Respondents, infringement requires a likelihood of confusion among the public, which is neither probable nor possible in the present case, as no reasonable consumer would confuse a sanitary pad with a pharmaceutical product intended for constipation relief.

The Respondents also argued that the Appellant is not entitled to discretionary relief due to suppression of material facts, including the Respondents' user affidavit demonstrating use of the Impugned Mark since 2017. They further submitted that the Appellant concealed its own earlier position in its reply to the Examination Report and in the counter-statement before the Registry, wherein it had expressly stated that sanitary napkins, pharmaceutical goods, and ayurvedic medicines are distinct, and that concurrent use of the marks would not cause confusion. The Respondents contended that the Appellant is estopped from approbating and reprobating and cannot now take a contradictory stand.

The Respondents emphasized that although the parties' goods fall under Class 5, they are entirely distinct and cannot be regarded as allied or cognate. The goods move through different trade channels, and there is no likelihood of confusion or even initial interest confusion due to their inherently different nature. They asserted that they have no intention of using the Impugned Mark for sanitary pads, napkins, or related goods, which is evident from their withdrawal of oppositions filed against the Appellant's applications for such goods. Additionally, the Respondents sought deletion of "hygiene and sanitary preparations" from the specification of goods in their own trademark application for the Impugned Mark, demonstrating their bona fides.

High Court's Analysis and Findings

The Delhi High Court observed that there is no dispute regarding the nature of the parties' respective goods. The Appellant uses the Subject Mark for sanitary napkins, sanitary towels, pads, and related feminine hygiene products, whereas the Respondents use the Impugned Mark for a pharmaceutical preparation intended to relieve constipation. The Court held that these goods are neither allied nor cognate. It agreed with the findings of the learned District Judge that the nature, purpose, trade channels, and consumer base of the respective goods are entirely distinct, leaving no likelihood of confusion arising from the concurrent use of the marks.

Key Legal Principle: No Monopoly Over Entire Class

The High Court emphasized a critical principle of trademark law: a trademark proprietor cannot claim monopoly over all goods within an entire class, particularly when the proprietor is not using the mark for certain goods falling within that class. This principle prevents trademark owners from warehousing rights over products they do not manufacture or sell, merely because those products fall within the same broad classification. The Court found that the Appellant's registration in Class 5 does not confer absolute rights over all pharmaceutical, sanitary, and health-related products within that class, but only extends to the specific goods for which the mark is actually used.

No Passing Off Established

The Court also found no case of passing off, noting that the packaging, presentation, and overall trade dress of the parties' products do not suggest any possibility of confusion. Consumers purchasing feminine hygiene products would not reasonably confuse them with constipation relief medication, given the entirely different purposes, purchasing contexts, and product characteristics.

Three-Fold Test for Interim Injunction

For the grant of an interim injunction, the Appellant was required to satisfy the three-fold test of: (i) establishing a prima facie case; (ii) demonstrating balance of convenience; and (iii) showing that irreparable harm would result if relief were denied. The Court held that the Appellant failed to establish a prima facie case. It further found that the balance of convenience favoured the Respondents, who had prima facie demonstrated continuous use of the Impugned Mark since 2017—nearly seven years before the filing of the suit.

Bona Fide Adoption and Industry Practice

The Respondents' adoption of the Impugned Mark was found to be bona fide and consistent with pharmaceutical industry practice, wherein parts of the chemical compound name are combined with additional descriptive elements to formulate a coined mark. In this case, the Respondents adopted "PRU" from the active ingredient Prucalopride and added "Ease" to indicate the relief provided by the medication. This method of trademark creation is widely recognized in pharmaceutical branding.

Irreparable Injury Not Established

With respect to irreparable injury, the Court held that the Appellant could always be compensated by damages should it ultimately succeed in the suit, and therefore no irreparable harm was established warranting the extraordinary remedy of interim injunction.

Significance

This judgment reinforces important limitations on the scope of trademark rights and clarifies that registration in a particular class does not grant blanket monopoly over all goods within that class. The decision emphasizes the importance of actual use, distinctiveness of goods, and likelihood of confusion in trademark infringement analysis. It protects legitimate competitors from overbroad trademark claims and ensures that trademark law serves its intended purpose of preventing consumer confusion rather than granting unjustified monopolies. The ruling also highlights the doctrine of estoppel, preventing parties from taking contradictory positions in different proceedings. This case will serve as valuable precedent in disputes involving similar marks used for different goods within the same class, particularly in the pharmaceutical and health products sectors.